arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Globus Medical, Inc.

GMED Health Care Medical/Dental Instruments
$78.29
▲ +0.0% Today
as of Sep 4, 16:49 ET
Last 30 days -2.84% Jul 28 → Sep 04
$77.30 $80.27 $83.23 $86.19 $89.16 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$77.23
High
$78.69
Low
$77.07
Volume
$1M
Avg Vol
$2M
Mkt Cap
$11.5B
P/E (TTM)
28.81
Beta
—
52w High
$101.40
52w Low
$54.15
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 20:10 Simply Wall St.
Globus Medical (GMED) Received CE Mark For Its Excelsius3D Imaging System
Sep 4 · 10:23 Medical Device Network
Globus Medical’s Excelsius3D imaging system receives CE mark
Sep 3 · 21:03 MT Newswires
Globus Medical Wins EU, UK Approval to Market Excelsius3D Imaging Platform
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$54
$101
51% of range
Avg surprise (last 3)
+8.9%
Avg reaction (last 2)
-1.7%
50% positive
Latest IV / EM
29%
EM ±4.5% · $78 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.05$0.24$0.54$0.83$1.12 Actual $0.48Actual $0.57Actual $0.01Actual $-0.05Actual $0.23Actual $0.38Actual $0.68Est $0.74Actual $0.86Est $0.76Actual $0.88Actual $1.12Est $0.92Actual $1.10 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$207M$415M$622M$829M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.10 — — — — financials
Thu May 7, 2026Mar/2026 $1.12 $0.92 +21.7% +64.7% -4.7% earnings
Tue Sep 30, 2025Sep 2025 $0.88 — — — — financials
Thu Aug 7, 2025Jun/2025 $0.86 $0.76 +13.2% — — earnings
Thu May 8, 2025Mar/2025 $0.68 $0.74 -8.1% — +1.3% earnings
Mon Sep 30, 2024Sep 2024 $0.38 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.23 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.05 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.01 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.57 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.48 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$790M$760M—$769M$745M$598M—$626M
Cost of revenue$241M$234M—$253M$249M$195M—$271M
Gross profit————————
Operating income$182M$150M—$137M$76M$97M—$48M
Net income$152M$124M—$119M$203M$75M—$52M
EPS (diluted)$1.10$0.90—$0.88$1.49$0.54—$0.38

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$508M$561M$526M—————
Inventory$811M$773M$759M$772M$772M$664M$659M$718M
Total current assets$2.22B$2.20B$2.13B$1.92B$1.73B$1.71B$2.18B$2.06B
Total assets$5.49B$5.44B$5.30B$5.10B$4.96B$4.71B$5.25B$5.09B
Long-term debt————————
Total liabilities$720M$707M$730M$697M$665M$623M$1.07B$1.02B
Total equity$4.77B$4.73B$4.57B$4.40B$4.30B$4.09B$4.18B$4.07B

Implied volatility — last 90 days

26%42%57%73%88% Jun 07 — IV 38% · EM ±5.3%Jun 08 — IV 36% · EM ±4.8%Jun 09 — IV 37% · EM ±4.6%Jun 10 — IV 38% · EM ±4.5%Jun 11 — IV 41% · EM ±4.6%Jun 12 — IV 28% · EM ±2.9%Jun 15 — IV 41% · EM ±2.9%Jun 16 — IV 39% · EM ±2.3%Jun 17 — IV 61% · EM ±2.6%Jun 19 — IV 32% · EM ±7.0%Jun 22 — IV 32% · EM ±6.8%Jun 23 — IV 30% · EM ±6.2%Jun 24 — IV 31% · EM ±6.3%Jun 25 — IV 32% · EM ±6.3%Jun 26 — IV 30% · EM ±5.8%Jun 29 — IV 31% · EM ±5.5%Jun 30 — IV 38% · EM ±6.5%Jul 01 — IV 36% · EM ±6.0%Jul 02 — IV 36% · EM ±5.9%Jul 03 — IV 38% · EM ±5.9%Jul 06 — IV 40% · EM ±5.6%Jul 07 — IV 42% · EM ±5.6%Jul 08 — IV 41% · EM ±5.2%Jul 09 — IV 41% · EM ±4.9%Jul 10 — IV 38% · EM ±4.2%Jul 13 — IV 53% · EM ±4.4%Jul 14 — IV 78% · EM ±5.7%Jul 15 — IV 46% · EM ±2.7%Jul 16 — IV 89% · EM ±3.7%Jul 20 — IV 48% · EM ±11.4%Jul 21 — IV 50% · EM ±11.7%Jul 22 — IV 61% · EM ±13.9%Jul 23 — IV 53% · EM ±11.8%Jul 24 — IV 57% · EM ±12.7%Jul 27 — IV 59% · EM ±12.4%Jul 28 — IV 62% · EM ±12.6%Jul 29 — IV 59% · EM ±11.9%Jul 30 — IV 56% · EM ±11.0%Jul 31 — IV 68% · EM ±13.0%Aug 03 — IV 70% · EM ±12.3%Aug 04 — IV 68% · EM ±11.7%Aug 05 — IV 68% · EM ±11.4%Aug 06 — IV 72% · EM ±11.6%Aug 07 — IV 39% · EM ±6.0%Aug 10 — IV 35% · EM ±4.9%Aug 11 — IV 38% · EM ±5.0%Aug 12 — IV 29% · EM ±3.6%Aug 13 — IV 31% · EM ±3.6%Aug 14 — IV 31% · EM ±3.4%Aug 17 — IV 39% · EM ±3.2%Aug 18 — IV 40% · EM ±2.9%Aug 19 — IV 34% · EM ±2.0%Aug 20 — IV 68% · EM ±2.8%Aug 24 — IV 30% · EM ±6.3%Aug 25 — IV 30% · EM ±6.1%Aug 26 — IV 30% · EM ±6.0%Aug 27 — IV 27% · EM ±5.2%Aug 28 — IV 27% · EM ±5.2%Aug 31 — IV 31% · EM ±5.4%Sep 01 — IV 30% · EM ±5.2%Sep 02 — IV 33% · EM ±5.5%Sep 03 — IV 27% · EM ±4.4%Sep 04 — IV 29% · EM ±4.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in